Humate-P is a trusted plasma-derived therapy used in the treatment of von Willebrand disease (VWD) and certain cases of hemophilia A. But have you ever wondered what the “P” in its name stands for?

The answer: Pasteurized.

This designation refers to one of the critical steps in its manufacturing process—pasteurization at 60°C for 10 hours. This controlled heating inactivates potential viruses, safeguarding patients while preserving the functional activity of von Willebrand factor (VWF) and factor VIII (FVIII).

Pasteurization is just one of several rigorous viral inactivation and removal steps applied to plasma-derived products. Alongside donor screening, viral testing, and purification techniques, it forms part of a multi-layered safety approach designed to ensure that every vial is as safe as it is effective.

Understanding these processes not only builds confidence in the product but also highlights the meticulous care taken to protect patient health.